TCL Archive Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says August 19, 1994
TCL Archive Reimbursement Of Some Anticancer Drugs Expected To Drop Sharply Under HHS Policy. June 30, 2000
TCL Archive Also Von Eschenbach role in industry program raises new concerns of conflict of interest. November 23, 2005
TCL Archive Reviewers Find I-ELCAP Is A Trial That Never Ends, With 90 Percent of Consent Forms Unobtainable April 29, 2011
